InterCure Ltd. - SIC # 6726 - UNIT INVESTMENT TRUSTS, FACE-AMOUNT CERTIFICATE OFFICES, AND CLOS

Ticker Exchange SIC # Website Latest Ticker
INCR Nasdaq 6726 www.intercure.co

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for InterCure Ltd.

InterCure Announces FY2024 Results and Provides Q1 2025 Update: Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million, Strong Start to 2025 - May 1st, 2025 8:00 pm
InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak - Feb 12th, 2025 11:35 pm
InterCure has Secured Funding of NIS 66M to support the recovery of Nir Oz Facility - Dec 20th, 2024 1:32 pm
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - Sep 1st, 2024 10:37 pm
InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million - Aug 29th, 2024 10:03 pm
InterCure Announces Expansion of its Strategic partnership with Cookies to Germany - Aug 28th, 2024 12:54 pm
InterCure to Participate in Canaccord Genuity’s 8th Annual Global Cannabis Conference - May 22nd, 2024 10:45 am